Immediate breast reconstruction delays radiotherapy and increases complicationJune 2, 2021Breast Cancer
Oncology PracticeTrastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first yearJune 2, 2021Metastatic Breast CancerBreast Cancer
Optimal Treatment for HR+/HER2- Breast Cancer Patients With Visceral Metastasis June 1, 2021Breast Cancer
Oncology PracticeEndocrine therapy benefits in premenopausal breast cancer differ by molecular riskMay 26, 2021Breast CancerMetastatic Breast Cancer
Oncology PracticeNew targeted treatments are major advances for HER2-positive breast cancerMay 21, 2021Breast CancerMetastatic Breast Cancer
Oncology PracticeGELATO trial: Chemoimmunotherapy may help in metastatic invasive lobular breast cancerMay 19, 2021Metastatic Breast CancerBreast Cancer
Oncology PracticeNo survival dip with neoadjuvant letrozole-palbociclib in NeoPAL studyMay 19, 2021Breast CancerMixed Topics
Oncology PracticeBERENICE: Further evidence of heart safety of dual HER2 blockadeMay 13, 2021Breast Cancer
Oncology PracticeThe power and promise of social media in oncologyMay 3, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeHyperprogression on immunotherapy: When outcomes are much worseApril 30, 2021ImmunotherapyNonmelanoma Skin CancerMelanomaBreast CancerGastroenterologyGastrointestinal CancerGenitourinary Cancer